Global Tissue Engineering Market Growth 2025-2031

Publication ID:

LPI07254774

Publication Date:

July 4, 2025

Pages:

128

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Tissue Engineering market size is predicted to grow from US$ 43190 million in 2025 to US$ 123830 million in 2031; it is expected to grow at a CAGR of 19.2% from 2025 to 2031.
Tissue Engineering is a process involving in-vitro development of tissues or organs. It is done to replace or support the function of defective or injured body part. Tissue engineering involves the application of biology and engineering for innovation of tissue substitutes that can maintain, restore and improve the function of ruptured human tissue. Products developed by this procedure are efficient and durable. Tissue engineering is gaining its popularity in various areas such as burn treatment or wound care, neurology products, orthopedics, urological products and others. On the basis of type of material used, tissue engineering and regeneration market can be segmented into synthetic, genetically modified and biological materials.
Global Tissue Engineering key players include Allergan, Integra Lifesciences, C. R. Bard, etc. Global top three manufacturers hold a share over 70%.
North America is the largest market, with a share about 50%, followed by Europe, and Asia Pacific, both have a share about 45 percent.
In terms of product, Biologically Derived Materials is the largest segment, with a share over 55%. And in terms of application, the largest application is Orthopedics, Musculoskeletal and Spine, followed by Skin and Integumentary, Cardiology and Vascular, Neurology, etc.
The 鈥淭issue Engineering Industry Forecast鈥� looks at past sales and reviews total world Tissue Engineering sales in 2024, providing a comprehensive analysis by region and market sector of projected Tissue Engineering sales for 2025 through 2031. With Tissue Engineering sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tissue Engineering industry.
This Insight Report provides a comprehensive analysis of the global Tissue Engineering landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tissue Engineering portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Tissue Engineering market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tissue Engineering and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tissue Engineering.
This report presents a comprehensive overview, market shares, and growth opportunities of Tissue Engineering market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Synthetic Materials
Biologically Derived Materials
Others
Segmentation by Application:
Neurology
Cardiology and Vascular
Skin and Integumentary
Orthopedics, Musculoskeletal and Spine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Allergan
Integra Lifesciences
C. R. Bard
Zimmer Biomet
Organogenesis
Osiris Therapeutics
Cryolife
ACell
Biocomposites
DSM
Episkin
J-TEC
Athersys
Biotime
B. Braun
International Stem Cell
Bio Tissue Technologies
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tissue Engineering market?
What factors are driving Tissue Engineering market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tissue Engineering market opportunities vary by end market size?
How does Tissue Engineering break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tissue Engineering Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Tissue Engineering by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Tissue Engineering by Country/Region, 2020, 2024 & 2031
2.2 Tissue Engineering Segment by Type
2.2.1 Synthetic Materials
2.2.2 Biologically Derived Materials
2.2.3 Others
2.3 Tissue Engineering Sales by Type
2.3.1 Global Tissue Engineering Sales Market Share by Type (2020-2025)
2.3.2 Global Tissue Engineering Revenue and Market Share by Type (2020-2025)
2.3.3 Global Tissue Engineering Sale Price by Type (2020-2025)
2.4 Tissue Engineering Segment by Application
2.4.1 Neurology
2.4.2 Cardiology and Vascular
2.4.3 Skin and Integumentary
2.4.4 Orthopedics, Musculoskeletal and Spine
2.4.5 Others
2.5 Tissue Engineering Sales by Application
2.5.1 Global Tissue Engineering Sale Market Share by Application (2020-2025)
2.5.2 Global Tissue Engineering Revenue and Market Share by Application (2020-2025)
2.5.3 Global Tissue Engineering Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Tissue Engineering Breakdown Data by Company
3.1.1 Global Tissue Engineering Annual Sales by Company (2020-2025)
3.1.2 Global Tissue Engineering Sales Market Share by Company (2020-2025)
3.2 Global Tissue Engineering Annual Revenue by Company (2020-2025)
3.2.1 Global Tissue Engineering Revenue by Company (2020-2025)
3.2.2 Global Tissue Engineering Revenue Market Share by Company (2020-2025)
3.3 Global Tissue Engineering Sale Price by Company
3.4 Key Manufacturers Tissue Engineering Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tissue Engineering Product Location Distribution
3.4.2 Players Tissue Engineering Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Tissue Engineering by Geographic Region
4.1 World Historic Tissue Engineering Market Size by Geographic Region (2020-2025)
4.1.1 Global Tissue Engineering Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Tissue Engineering Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tissue Engineering Market Size by Country/Region (2020-2025)
4.2.1 Global Tissue Engineering Annual Sales by Country/Region (2020-2025)
4.2.2 Global Tissue Engineering Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tissue Engineering Sales Growth
4.4 APAC Tissue Engineering Sales Growth
4.5 Europe Tissue Engineering Sales Growth
4.6 Middle East & Africa Tissue Engineering Sales Growth
5 Americas
5.1 Americas Tissue Engineering Sales by Country
5.1.1 Americas Tissue Engineering Sales by Country (2020-2025)
5.1.2 Americas Tissue Engineering Revenue by Country (2020-2025)
5.2 Americas Tissue Engineering Sales by Type (2020-2025)
5.3 Americas Tissue Engineering Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tissue Engineering Sales by Region
6.1.1 APAC Tissue Engineering Sales by Region (2020-2025)
6.1.2 APAC Tissue Engineering Revenue by Region (2020-2025)
6.2 APAC Tissue Engineering Sales by Type (2020-2025)
6.3 APAC Tissue Engineering Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tissue Engineering by Country
7.1.1 Europe Tissue Engineering Sales by Country (2020-2025)
7.1.2 Europe Tissue Engineering Revenue by Country (2020-2025)
7.2 Europe Tissue Engineering Sales by Type (2020-2025)
7.3 Europe Tissue Engineering Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tissue Engineering by Country
8.1.1 Middle East & Africa Tissue Engineering Sales by Country (2020-2025)
8.1.2 Middle East & Africa Tissue Engineering Revenue by Country (2020-2025)
8.2 Middle East & Africa Tissue Engineering Sales by Type (2020-2025)
8.3 Middle East & Africa Tissue Engineering Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tissue Engineering
10.3 Manufacturing Process Analysis of Tissue Engineering
10.4 Industry Chain Structure of Tissue Engineering
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tissue Engineering Distributors
11.3 Tissue Engineering Customer
12 World Forecast Review for Tissue Engineering by Geographic Region
12.1 Global Tissue Engineering Market Size Forecast by Region
12.1.1 Global Tissue Engineering Forecast by Region (2026-2031)
12.1.2 Global Tissue Engineering Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tissue Engineering Forecast by Type (2026-2031)
12.7 Global Tissue Engineering Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Tissue Engineering Product Portfolios and Specifications
13.1.3 Allergan Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Integra Lifesciences
13.2.1 Integra Lifesciences Company Information
13.2.2 Integra Lifesciences Tissue Engineering Product Portfolios and Specifications
13.2.3 Integra Lifesciences Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Integra Lifesciences Main Business Overview
13.2.5 Integra Lifesciences Latest Developments
13.3 C. R. Bard
13.3.1 C. R. Bard Company Information
13.3.2 C. R. Bard Tissue Engineering Product Portfolios and Specifications
13.3.3 C. R. Bard Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 C. R. Bard Main Business Overview
13.3.5 C. R. Bard Latest Developments
13.4 Zimmer Biomet
13.4.1 Zimmer Biomet Company Information
13.4.2 Zimmer Biomet Tissue Engineering Product Portfolios and Specifications
13.4.3 Zimmer Biomet Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Zimmer Biomet Main Business Overview
13.4.5 Zimmer Biomet Latest Developments
13.5 Organogenesis
13.5.1 Organogenesis Company Information
13.5.2 Organogenesis Tissue Engineering Product Portfolios and Specifications
13.5.3 Organogenesis Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Organogenesis Main Business Overview
13.5.5 Organogenesis Latest Developments
13.6 Osiris Therapeutics
13.6.1 Osiris Therapeutics Company Information
13.6.2 Osiris Therapeutics Tissue Engineering Product Portfolios and Specifications
13.6.3 Osiris Therapeutics Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Osiris Therapeutics Main Business Overview
13.6.5 Osiris Therapeutics Latest Developments
13.7 Cryolife
13.7.1 Cryolife Company Information
13.7.2 Cryolife Tissue Engineering Product Portfolios and Specifications
13.7.3 Cryolife Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cryolife Main Business Overview
13.7.5 Cryolife Latest Developments
13.8 ACell
13.8.1 ACell Company Information
13.8.2 ACell Tissue Engineering Product Portfolios and Specifications
13.8.3 ACell Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 ACell Main Business Overview
13.8.5 ACell Latest Developments
13.9 Biocomposites
13.9.1 Biocomposites Company Information
13.9.2 Biocomposites Tissue Engineering Product Portfolios and Specifications
13.9.3 Biocomposites Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Biocomposites Main Business Overview
13.9.5 Biocomposites Latest Developments
13.10 DSM
13.10.1 DSM Company Information
13.10.2 DSM Tissue Engineering Product Portfolios and Specifications
13.10.3 DSM Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 DSM Main Business Overview
13.10.5 DSM Latest Developments
13.11 Episkin
13.11.1 Episkin Company Information
13.11.2 Episkin Tissue Engineering Product Portfolios and Specifications
13.11.3 Episkin Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Episkin Main Business Overview
13.11.5 Episkin Latest Developments
13.12 J-TEC
13.12.1 J-TEC Company Information
13.12.2 J-TEC Tissue Engineering Product Portfolios and Specifications
13.12.3 J-TEC Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 J-TEC Main Business Overview
13.12.5 J-TEC Latest Developments
13.13 Athersys
13.13.1 Athersys Company Information
13.13.2 Athersys Tissue Engineering Product Portfolios and Specifications
13.13.3 Athersys Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Athersys Main Business Overview
13.13.5 Athersys Latest Developments
13.14 Biotime
13.14.1 Biotime Company Information
13.14.2 Biotime Tissue Engineering Product Portfolios and Specifications
13.14.3 Biotime Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Biotime Main Business Overview
13.14.5 Biotime Latest Developments
13.15 B. Braun
13.15.1 B. Braun Company Information
13.15.2 B. Braun Tissue Engineering Product Portfolios and Specifications
13.15.3 B. Braun Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 B. Braun Main Business Overview
13.15.5 B. Braun Latest Developments
13.16 International Stem Cell
13.16.1 International Stem Cell Company Information
13.16.2 International Stem Cell Tissue Engineering Product Portfolios and Specifications
13.16.3 International Stem Cell Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 International Stem Cell Main Business Overview
13.16.5 International Stem Cell Latest Developments
13.17 Bio Tissue Technologies
13.17.1 Bio Tissue Technologies Company Information
13.17.2 Bio Tissue Technologies Tissue Engineering Product Portfolios and Specifications
13.17.3 Bio Tissue Technologies Tissue Engineering Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Bio Tissue Technologies Main Business Overview
13.17.5 Bio Tissue Technologies Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂